Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
FTAAU FTAC Athena Acquisition Corp
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund
LGO Largo Inc
ONTO Onto Innovation Inc
OFED Oconee Federal Financial Corp
WKEY Wisekey International Holding AG
FPH Five Point Holdings LLC
FATE Fate Therapeutics Inc
MCD McDonald's Corp
Go

Health Care : Biotechnology | Large Cap Value

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Closing Price: $146.28

Day's Change: -1.12 (-0.76%)

Bid: --

Ask: --

B/A Size: --

Day's High: 147.68

Day's Low: 146.02

Volume (Light) Volume: 4,591,481 10-day average volume: 6,392,098: 4,591,481

NVIDIA Corp. Stock Rises Tuesday, Outperforms Market

5:15 pm ET January 17, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of NVIDIA Corp. (NVDA) rallied 4.75% to $177.02 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.20% to 3,990.97 and Dow Jones Industrial Average falling 1.14% to 33,910.85. This was the stock's seventh consecutive day of gains. NVIDIA Corp. closed $112.44 below its 52-week high ($289.46), which the company achieved on March 29th.

Trading volume (51.0 M) eclipsed its 50-day average volume of 46.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 17, 2023.

(END) Dow Jones Newswires

January 17, 2023 17:15 ET (22:15 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and